We are live on
!
Find out more
Agios Pharmaceuticals
AGIO
AGIO
205 hedge funds and large institutions have $2.51B invested in Agios Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 48 funds opening new positions, 51 increasing their positions, 82 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
78% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 27
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
38% more capital invested
Capital invested by funds: $1.81B → $2.51B (+$695M)
10% more funds holding
Funds holding: 186 → 205 (+19)
6% more call options, than puts
Call options by funds: $12.4M | Put options by funds: $11.8M
7.91% less ownership
Funds ownership: 110.34% → 102.43% (-7.9%)
38% less repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 82
Holders
205
Holders Change
+19
Holders Change %
+10.22%
% of All Funds
2.96%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
48
Increased
51
Reduced
82
Closed
27
Calls
$12.4M
Puts
$11.8M
Net Calls
+$655K
Net Calls Change
+$3.67M
Top Buyers
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$43M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$30.9M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$27.6M |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$16.8M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$16.2M |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$36.9M |
| 2 |
AC
Armistice Capital
New York
|
-$31.9M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$31.7M |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$27.2M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$26M |
